Latest News

Check out what is happening at HCD Economics

April 2021

Study undertaken in Ultra-rare paediatric disease

Data to be drawn from a descriptive, retrospective, cross sectional burden of illness study design developed by HCD Economics and University of Chester A peer-review manuscript published on 7th January 2021, in the journal ‘Expert Review of Pharmacoeconomics and Outcomes Research’ (impact factor 2.032), reports on the study rationale and protocol of the PICTURE study. PFIC Burden of Illness: Quantifying the global socio-economic burden The PICTURE study will employ a study design developed by HCD Economics and University of Chester in 2014. Founded on the principle of Public and Patient Involvement and Engagement (PPIE), the methodology has generated real-world evidence that can inform and support advocacy for clinical implementation of new therapies including rare diseases.
Continue Reading
March 2021

‘Collaboration is vital – especially in rare disease’ – Professor Keith Abrams, University of Leicester

Jamie O’Hara joined the panel of yesterday’s collaborative webinar (24th Mach 2021), entitled ‘Economic Modelling in Rare Diseases’. The panel involved three leading academic centres, University of Leicester, York and Sheffield, digital research organisation Vitaccess, and leading health economic organisations Source Health Economics and HCD Economics. Jamie participated alongside panellists; Professor Keith Abrams, Professor John Brazier, Dr Jill Carlton, Josie Godfrey, Dr Mark Larkin and Juliet Mumby-Croft.
Continue Reading
March 2021

HCD Economics launches 2021 NMD real world evidence initiative

Combining our commitment to the rare disease community with our established leadership in patient and public engagement led research (PPIE), HCD Economics is announcing a 2021 commitment to identify and undertake research intended to build a repository of real-world evidence (RWE) that can be applied to NMD community evidence-based advocacy initiatives and other programmes. The commitment is to invest and develop partnerships for a RWE programme to support access for NMD patients to new and emerging novel therapies in the treatment and management of NMD.
Continue Reading
Scroll for more

About us

HCD was created out of an alliance with University of Chester, charities and health service sectors in reponse to the ever-growing demand for economic analysis within healthcare and specifically the need for health economics and business intelligence within the public and third sectors.

Through these partnerships, HCD provides a unique insight and perspective, focusing our analyses on what matters to patients as well as decision-makers, all undertaken with academic rigour, independence and credibility.

Continue Reading
Scroll for more

Our Process

We have created core partnerships with University of Chester and leading patient charities that underpin our approach.

Higher education

Academia has a leading role to play in providing an independent, credible evidence-base as well as evaluating current and new ways of delivering healthcare.

Charities

Our partnerships with patient charities ensure that any analyses we undertake reflect the day-to-day realities of living with a particular condition.

Data

We apply primary or secondary real world data sources depending on research needs and questions. From ethically reviewed burden of illness studies and bespoke service primary data, to secondary sourced disease registries and episode statistics.

Scroll for more

Get in touch

...and one of our experts will get back to you ASAP.

Please be advised that we will not use your details for marketing purposes
Scroll for more
Scroll for more